One Charles Private Wealth Services
CATX icon

One Charles Private Wealth Services’s Perspective Therapeutics CATX Stock Holding History

One Charles Private Wealth Services’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,000
Closed -$12K – 31
2020
Q3 		$12K Hold
2,000
– – 0.01% 35
2020
Q2 		$11K Buy
+2,000
New +$12.9K 0.01% 93

Other funds holding CATX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Highland Private Wealth Management
Highland Private Wealth Management Bellevue, Washington $620M AUM 18.88% 1-Year Est. Return
Cahaba Wealth Management
Cahaba Wealth Management Atlanta, Georgia $1.66B AUM 9.31% 1-Year Est. Return
Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Virtu Financial
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Anson Funds Management
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

One Charles Private Wealth Services's CATX Position: Q4 2020 in Review

One Charles Private Wealth Services sold out of Perspective Therapeutics (CATX) in Q4 2020, closing a stake of 2,000 shares — an estimated $12K sold.

One Charles Private Wealth Services first reported a position in CATX in Q2 2020 and held it in 2 quarters. The position peaked at $12K in Q3 2020. 43 funds tracked by Wall St. Rank hold CATX as of Q4 2020.

  • One Charles Private Wealth Services reported no remaining Perspective Therapeutics position as of Q4 2020 after selling out during the quarter.
  • One Charles Private Wealth Services sold 2,000 Perspective Therapeutics shares in Q4 2020, an estimated $12K.
  • One Charles Private Wealth Services first reported a position in Perspective Therapeutics in Q2 2020 and held it in 2 quarters.
  • One Charles Private Wealth Services's Perspective Therapeutics position peaked at $12K in Q3 2020.
  • 43 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q4 2020.

Based on One Charles Private Wealth Services's 13F filing for Q4 2020, filed 29 Jan 2021.